Patents by Inventor Stefania PETROSINO

Stefania PETROSINO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain caused by osteoarthritis and epithelial dysfunctions
    Patent number: 11491122
    Abstract: Described herein is the use of Adelmidrol in the treatment of epithelial dysfunctions. In particular, described herein is Adelmidrol for use in the treatment of epithelial tissue dysfunctions in a human being or animal, wherein said Adelmidrol causes an increase of the endogenous levels of Palmitoylethanolamide without inhibiting the activity of the Palmitoylethanolamide-degrading FAAH and NAAA enzymes.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: November 8, 2022
    Assignee: Epitech Group S.p.A.
    Inventors: Maria Federica Della Valle, Francesco Della Valle, Vincenzo Di Marzo, Stefania Petrosino, Barbara Costa, Gabriele Marcolongo, Daniele Grassi
  • Use of Adelmidrol in the Treatment of Epithelial Dysfunctions
    Publication number: 20190224145
    Abstract: Described herein is the use of Adelmidrol in the treatment of epithelial dysfunctions. In particular, described herein is Adelmidrol for use in the treatment of epithelial tissue dysfunctions in a human being or animal, wherein said Adelmidrol causes an increase of the endogenous levels of Palmitoylethanolamide without inhibiting the activity of the Palmitoylethanolamide-degrading FAAH and NAAA enzymes.
    Type: Application
    Filed: April 4, 2019
    Publication date: July 25, 2019
    Applicant: Epitech Group S.p.A.
    Inventors: Maria Federica Della Valle, Francesco Della Valle, Vincenzo Di Marzo, Stefania Petrosino, Barbara Costa, Gabriele Marcolongo, Daniele Grassi
  • Use of Adelmidrol in the Treatment of Epithelial Dysfunctions
    Publication number: 20170209395
    Abstract: Described herein is the use of Adelmidrol in the treatment of epithelial dysfunctions. In particular, described herein is Adelmidrol for use in the treatment of epithelial tissue dysfunctions in a human being or animal, wherein said Adelmidrol causes an increase of the endogenous levels of Palmitoylethanolamide without inhibiting the activity of the Palmitoylethanolamide-degrading FAAH and NAAA enzymes.
    Type: Application
    Filed: April 7, 2017
    Publication date: July 27, 2017
    Applicant: Epitech Group S.r.l.
    Inventors: Maria Federica Della Valle, Francesco Della Valle, Vincenzo Di Marzo, Stefania Petrosino, Barbara Costa, Gabriele Marcolongo, Daniele Grassi
  • Use of Adelmidrol in the Treatment of Epithelial Dysfunctions
    Publication number: 20160008301
    Abstract: The described herein is the use of Adelmidrol in the treatment of epithelial dysfunctions. In particular, described herein is Adelmidrol for use in the treatment of epithelial tissue dysfunctions in a human being or animal, wherein said Adelmidrol causes an increase of the endogenous levels of Palmitoylethanolamide without inhibiting the activity of the Palmitoylethanolamide-degrading FAAH and NAAA enzymes.
    Type: Application
    Filed: July 7, 2015
    Publication date: January 14, 2016
    Applicant: Epitech Group S.r.l.
    Inventors: Maria Federica DELLA VALLE, Francesco DELLA VALLE, Vincenzo DI MARZO, Stefania PETROSINO, Barbara COSTA, Gabriele MARCOLONGO, Daniele GRASSI